Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Festival Offer
This Diwali, Light up your portfolio with MoneyWorks4me Superstars starting @ ₹ 7,999 ₹ 5,999 (Offer valid till 3rd Nov 21)
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Ameya Laboratories Ltd Stock Analysis

Small Cap
Evaluated by 127 users | BSE: 532981 | NSE: |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12TTM
Return on Capital Employed 014.24%27.2%32.73%37.18%31.64%15.46%13.33%11.04%7.83%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 026.362.790.3108150161204273268160
Y-o-Y Gr. Rt.-NA138%44.1%19.4%39.5%6.9%27.2%33.4%-1.7%-
Adjusted EPS (Rs.) 00.050.140.390.831.090.680.880.660.16-0.81
Y-o-Y Gr. Rt.-NA180%178.6%112.8%31.3%-37.6%29.4%-25%-75.8%-
Book Value per Share (Rs.) 00.380.510.861.983.125.786.46.486.70.00
Adjusted Net Profit 00.52.15.713.21816.321.216.13.8-20
Net Op. Cash Flow (Rs. Cr.) 03.7-0.7-4.74.6-6.6-42.41328.5-10.1-
Debt to Cash Flow from Ops 01.82-15.38-3.745.73-6.14-0.966.233.4-12.92-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Ameya Laboratories Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales NA20%18.6%-1.7%
Adjusted EPS NA-28.1%-38.3%-75.8%
Book Value per Share 027.65.13.4
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12TTM
Return on Equity (%) 011.7533.5854.5758.7643.1616.5213.799.952.34-24.18
Operating Profit Margin (%) 07.539.3112.092122.3720.8717.7216.9114.766.85
Net Profit Margin (%) 02.063.36.3112.2211.9510.1510.355.891.43-12.36
Debt to Equity 01.61.391.40.840.790.290.530.610.8-
Working Capital Days 00111113126160271296221238-
Cash Conversion Cycle 0011244889169182143169-
Loading price chart...
Entity Percentage Holding
Promoters 39.30%
Institutions 0.79%
Non-Institutions 59.90%
Pledged *52.9937.4245.1245.1265.9666.1269.8969.1674.8473.79
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Data is not available for this company.

Anu's Laboratories is an ISO 9001:2000 certified company established in 1996, engaged in the manufacture of quality drug intermediates to meet the needs of international customers. The optimized process of 2, 4- Dichloro- 5 Fluoro Acetophenone has enabled the brand to establish itself as the flagship product of the organization. It is available to its wide customer base as a competitive product of the highest quality. Other high quality intermediates such as Chlorohexanone, 1, 3-Dibromo

Anu's Laboratories is an ISO 9001:2000 certified company established in 1996, engaged in the manufacture of quality drug intermediates to meet the needs of international customers. The optimized process of 2, 4- Dichloro- 5 Fluoro Acetophenone has enabled the brand to establish itself as the flagship product of the organization. It is available to its wide customer base as a competitive product of the highest quality. Other high quality intermediates such as Chlorohexanone, 1, 3-Dibromo Propane are also available to its valued customers. The company is also producing Methyl- 4 (4-Chloro 1 oxo butyl), a Di-Methyl Acetate. Its state-of-the-art R&D facilities, located at Balanagar, Hyderabad, support the process of product development, contract research and customised synthesis programmes of the organization.

The company has entered into a job work agreement with Nitya Laboratories for manufacture of Sodium Methoxide or Sodium Methylate Solution and Powder and CIS (+) Hydroxide Lactum. Nitya Laboratories is one of the promoter group company involved in the manufacturing of fine chemicals and intermediates.

In 2010  Anu's Laboratories acquired Stilbene Chemicals Ltd.

Products

  • Basic Intermediates
  • Advanced Intermediates
  • Fine Chemicals
  • Products in pipeline

Achievements

  • The company received the state level Best SSI Entrepreneur Award for the year 2001-02 from the AP state government. 
  • The company was awarded the Market Penetration Leadership in the Indian Pharmaceutical Intermediates Market by M/s Frost & Sullivan for the year 2005.
  • Consistent and long-term relationship with customers.
  • Developed ‘A Cleaner Production Process’ by recovering by-products of commercial value from waste water.
  • Challenged the Chinese monopoly & attained leadership position in many of its products.
  • Developed and commercialized new intermediates; many more in pipeline.
  • ISO 9001 and Q9001-2000 Certifications.
  • Anu's R&D recognized by Department of Scientific and Industrial Research (DSIR), Government of India, New Delhi.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback